The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Kenney Christopher John since 2022.
This trader's CIK number is 1880129.
At the time of last reporting, Kenney Christopher John was the Chief Medical Officer of Xenon Pharmaceuticals Inc.. (stock ticker symbol XENE).
Also see all insider trading activities at Xenon Pharmaceuticals Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | XENE | 0 | $0 | 700 | $24,507 | 0 | $0 |
| 2022 | XENE | 700 | $20,167 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-03-24 | XENE | Sale | 700 | 35.01 | 24,507 |
| 2022-01-21 | XENE | Buy | 700 | 28.81 | 20,167 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kenney Christopher John (Chief Medical Officer of Xenon Pharmaceuticals Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.